GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (XTER:BNN) » Definitions » Days Sales Outstanding

BRAIN Biotech AG (XTER:BNN) Days Sales Outstanding : 54.91 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BRAIN Biotech AG Days Sales Outstanding?

BRAIN Biotech AG's average Accounts Receivable for the three months ended in Mar. 2024 was €8.71 Mil. BRAIN Biotech AG's Revenue for the three months ended in Mar. 2024 was €14.47 Mil. Hence, BRAIN Biotech AG's Days Sales Outstanding for the three months ended in Mar. 2024 was 54.91.

The historical rank and industry rank for BRAIN Biotech AG's Days Sales Outstanding or its related term are showing as below:

XTER:BNN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.4   Med: 61.26   Max: 92.03
Current: 55.81

During the past 9 years, BRAIN Biotech AG's highest Days Sales Outstanding was 92.03. The lowest was 54.40. And the median was 61.26.

XTER:BNN's Days Sales Outstanding is ranked better than
59.72% of 1522 companies
in the Chemicals industry
Industry Median: 63.735 vs XTER:BNN: 55.81

BRAIN Biotech AG's Days Sales Outstanding increased from Mar. 2023 (49.05) to Mar. 2024 (54.91).


BRAIN Biotech AG Days Sales Outstanding Historical Data

The historical data trend for BRAIN Biotech AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG Days Sales Outstanding Chart

BRAIN Biotech AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only 60.77 59.93 61.26 54.40 57.64

BRAIN Biotech AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.05 49.99 57.66 67.69 54.91

Competitive Comparison of BRAIN Biotech AG's Days Sales Outstanding

For the Specialty Chemicals subindustry, BRAIN Biotech AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BRAIN Biotech AG's Days Sales Outstanding Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BRAIN Biotech AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BRAIN Biotech AG's Days Sales Outstanding falls into.



BRAIN Biotech AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BRAIN Biotech AG's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

Days Sales Outstanding (A: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (8.036 + 9.442) / 2 ) / 55.335*365
=8.739 / 55.335*365
=57.64

BRAIN Biotech AG's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0 + 8.71) / 1 ) / 14.474*365 / 4
=8.71 / 14.474*365 / 4
=54.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BRAIN Biotech AG  (XTER:BNN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


BRAIN Biotech AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BRAIN Biotech AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


BRAIN Biotech AG (XTER:BNN) Business Description

Traded in Other Exchanges
Address
Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.
Executives
Dr. Michael Majerus Supervisory Board
Dr. Georg Kellinghusen Supervisory Board
Michael Schneiders Board of Directors
Adriaan Moelker Board of Directors
Lukas Linnig Board of Directors

BRAIN Biotech AG (XTER:BNN) Headlines

No Headlines